z-logo
open-access-imgOpen Access
Can Placental Corticotropin-Releasing Hormone Inform Timing of Antenatal Corticosteroid Administration?
Author(s) -
Danielle A. Swales,
Leah A. Grande,
Deborah A. Wing,
Michelle N. Edelmann,
Laura M. Glynn,
Curt A. Sandman,
Roger Smith,
M.E. Bowman,
Elysia Poggi Davis
Publication year - 2018
Publication title -
the journal of clinical endocrinology and metabolism
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.206
H-Index - 353
eISSN - 1945-7197
pISSN - 0021-972X
DOI - 10.1210/jc.2018-00956
Subject(s) - corticosteroid , administration (probate law) , medicine , corticotropin releasing hormone , hormone , adrenocorticotropic hormone , endocrinology , political science , law
Antenatal corticosteroids are commonly administered to pregnant women at risk for delivering between 23 and 34 gestational weeks; they provide crucial benefits to fetal lung maturation and reduce risk for neonatal morbidity and mortality. Corticosteroids are maximally efficacious for lung maturation when administered within 2 to 7 days of delivery. Accurately identifying the timing of preterm delivery is thus critical to ensure that antenatal corticosteroids are administered within a week of delivery and to avoid unnecessary administration to women who will deliver at term. A plausible biomarker for predicting time of delivery is placental corticotropin-releasing hormone (pCRH).

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom